cytarabine has been researched along with Respiration Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirabayashi, K; Ishii, E; Koike, K; Nakamura, T; Saito, S; Sakashita, K; Shiohara, M; Takahashi, D; Tanaka, M; Yanagisawa, R | 1 |
| Caillot, D; Chastang, C; Chomienne, C; Condé, E; De Botton, S; de la Serna, J; Degos, L; Dombret, H; Fenaux, P; Gardembas, M; Gardin, C; Geiser, K; Guerci, A; Lefrere, F; Makhoul, DC; Miguel, JS; Reman, O; Sanz, M; Stamatoulas, A; Zittoun, R | 1 |
1 trial(s) available for cytarabine and Respiration Disorders
| Article | Year |
|---|---|
Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
Topics: Acute Kidney Injury; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Cytarabine; Dexamethasone; Disease-Free Survival; Female; Humans; Incidence; Leukemia, Promyelocytic, Acute; Leukocyte Count; Life Tables; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Proportional Hazards Models; Remission Induction; Respiration Disorders; Survival Rate; Syndrome; Treatment Outcome; Tretinoin | 1998 |
1 other study(ies) available for cytarabine and Respiration Disorders
| Article | Year |
|---|---|
Retrospective analysis of risk factors for development of liver dysfunction in transient leukemia of Down syndrome.
Topics: Cytarabine; Disease Progression; Down Syndrome; Female; Hepatomegaly; Humans; Hyaluronic Acid; Immunosuppressive Agents; Infant; Infant, Newborn; Leukemia; Liver Cirrhosis; Liver Diseases; Male; Respiration Disorders; Retrospective Studies; Risk Factors; Splenomegaly | 2011 |